Results 81 to 90 of about 411,072 (381)

Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis [PDF]

open access: yes, 2016
Objective: First-degree atrioventricular block is frequently encountered in clinical practice and is generally considered a benign process. However, there is emerging evidence that prolonged PR interval may be associated with adverse outcomes. This study
Barker, Diane   +11 more
core   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen   +4 more
wiley   +1 more source

Isthmus Dependent Atrial Flutter Cycle Length Correlates with Right Atrial Cross-Sectional Area

open access: yesIndian Pacing and Electrophysiology Journal, 2009
Background: Right atrial flutter cycle length can prolong in the presence of antiarrhythmic drug therapy. We hypothesized that the cycle length of right atrial isthmus dependent flutter would correlate with right atrial cross-sectional area measurements.
Kousik Krishnan   +6 more
doaj  

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram [PDF]

open access: yes, 2004
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Neither the natural history of AF nor its response to therapy are sufficiently predictable by clinical and echocardiographic parameters.
Bollmann, Andreas   +4 more
core  

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Atrial standstill in a horse with cardiac glycoside intoxication [PDF]

open access: yes, 2012
C
De Clercq, Dominique   +4 more
core   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

Management of paroxysmal atrial flutter that occurred in an outpatient prior to dental surgery: a case report

open access: yesBMC Oral Health, 2019
Background It is essential to accomplish the appropriate emergency care particularly in patients undergoing stressful dento-oral surgical procedures.
Hajime Shimoda, Tetsu Takahashi
doaj   +1 more source

Ablation of Post Transplant Atrial Flutter and Pseudo-Fibrillation Using Magnetic Navigation via a Superior Approach

open access: yesIndian Pacing and Electrophysiology Journal, 2012
Ablation of cavotricuspid isthmus flutter and atrial tachycardia in a complex substrate has never been reported using remote navigation via superior approach.
Roderick Tung, MD   +2 more
doaj   +1 more source

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants

open access: yesESC Heart Failure, 2022
Aims Atrial fibrillation (AF)/atrial flutter is common during cardiac amyloidosis (CA). Electrical cardioversion (EC) is a strategy to restore sinus rhythm (SR). However, left atrial thrombus (LAT) represents a contraindication for EC.
Olivier Touboul   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy